Advertisement

Extracorporeal Shock Wave Lithotripsy for Gallstones: The “No Touch” Technique

  • A. Darzi
  • F. B. V. Keane

Abstract

Extracorporeal shock wave lithotripsy (ESWL*) is successful in fragmenting gallstones, but less than 28% of patients with gallstone disease fulfill the criteria considered suitable for this treatment.1 Many patients are considered unsuitable because their stones are radiopaque, more than three in number, or larger than 3 cm in diameter. However, no clinical studies have been done to substantiate these current selection criteria.

In this study, an EDAP LT-01 lithotripter was employed in combination with dissolution therapy. The selection criteria were significantly broadened to include patients with radiolucent stones of any size and number, and radiopaque stones smaller than 3 cm in diameter. To date 88 patients with gallstones have received treatment. All patients received up to six sessions of piezoelectric lithotripsy (PEL) (6,000 shock waves per session) without sedation or analgesia.

Early results demonstrated complete gallstone clearance in 29 patients (mean follow-up 6.3 months) and more than 50% clearance in 14 patients (mean follow-up, 6.7 months) still undergoing therapy. Of those patients with a successful outcome, only 13 would have satisfied traditional selection criteria. There were no significant complications. This study suggests that the previously accepted selection criteria underestimate the number of patients suitable for gallstone ESWL and dissolution therapy.

Keywords

Shock Wave Shock Wave Lithotripsy Extracorporeal Shock Wave Lithotripsy Gallstone Disease Extracorporeal Shock Wave Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sackmann M, Delius M, Sauerbruch T, et al: Shock wave lithotripsy of gallstones: the first 175 patients. NEJM 318: 393, 1988.PubMedCrossRefGoogle Scholar
  2. 2.
    Chaussy C, Schmiedt E, Jocham D, et al: First clinical experience with extracorporeal induced destruction of kidney stones by shock waves. J Urol 127: 417, 1982.PubMedGoogle Scholar
  3. 3.
    Sauerbruch T, Delius M, Paumgartner G: Fragmentation of gallstones by extracorporeal shock waves. NEJM 314: 818, 1986.PubMedCrossRefGoogle Scholar
  4. 4.
    Hood KA, Keightley A, Dowling RH, et al: Piezo-ceramic lithotripsy of gallbladder stones: initial experience in 38 patients. The Lancet 1: 1322, 1988.CrossRefGoogle Scholar
  5. 5.
    Fromm H: Gallstone dissolution therapy, current status and future prospects. Gastroenterology 91: 1560, 1986.PubMedGoogle Scholar
  6. 6.
    Fromm H, Roat JW, Gonzales V, et al: Comparative efficacy and side effects of ursodeoxycholic acids in dissolving gallstones: a double-blind controlled study. Gastroenterology 85: 1257, 1983.PubMedGoogle Scholar
  7. 7.
    Ellis WR, Somerville KV, Whitten BH, et al: Pilot study of combination treatment for gallstones with medium dose chenodeoxycholic acid and a terpene preparation. Br Med J 289: 153, 1984.CrossRefGoogle Scholar
  8. 8.
    Coptcoat MJ, Miller RA, Wickham JEA: Lithotripsy II. London: BDI Publishing, 1987.Google Scholar
  9. 9.
    Carey PD, Darzi A, Monson JRT, et al: In vitro gallstone dissolution by extracorporeal shock wave therapy: the influence of frequency and power. Ir J Med Sci,in press, 1988.Google Scholar
  10. 10.
    Darzi A, Monson JRT, Kay E, et al: Extracorporeal shock wave therapy for gallstones may cause significant soft tissue damage. Gastroenterology 94: A87, 1988.Google Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • A. Darzi
    • 1
  • F. B. V. Keane
    • 1
  1. 1.Department of SurgeryMeath Hospital and Adelaide HospitalDublinIreland

Personalised recommendations